Your browser doesn't support javascript.
May we target double-membrane vesicles and oxysterol-binding protein to combat SARS-CoV-2 infection?
Shahmohamadnejad, Shiva; Nabavi, Seyed Fazel; Habtemariam, Solomon; Sarkar, Kasturi; Sil, Parames C; Dowran, Razieh; Nabavi, Seyed Mohammad.
  • Shahmohamadnejad S; Department of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Nabavi SF; Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Habtemariam S; Division of Translational Medicine, Baqiyatallah Hospital, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Sarkar K; Pharmacognosy Research Laboratories & Herbal Analysis Services UK, University of Greenwich, Chatham-Maritime, Kent, UK.
  • Sil PC; Department of Microbiology, St. Xavier's College, Kolkata, India.
  • Dowran R; Department of Molecular Medicine, Bose Institute, Kolkata, India.
  • Nabavi SM; Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Cell Biol Int ; 44(9): 1770-1772, 2020 09.
Article in English | MEDLINE | ID: covidwho-361193
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Receptors, Steroid / Cell Membrane / Drug Delivery Systems / Coronavirus Infections / Betacoronavirus Limits: Humans Language: English Journal: Cell Biol Int Year: 2020 Document Type: Article Affiliation country: Cbin.11400

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Receptors, Steroid / Cell Membrane / Drug Delivery Systems / Coronavirus Infections / Betacoronavirus Limits: Humans Language: English Journal: Cell Biol Int Year: 2020 Document Type: Article Affiliation country: Cbin.11400